SCHEMBL2884732

SCHEMBL2884732

COC(=O)c1cc(C(=O)c2ccc(NC(=O)c3cccc(Cl)c3)cc2)ccc1F

nearest known ligand 0.55

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 6/20 0.55
MEN1 O00255 5/20 0.55
RAB9A P51151 5/20 0.55
SMN1; SMN2 Q16637 4/20 0.55
NPC1 O15118 3/20 0.55
PLAU P00749 1/20 0.52
ALDH1A1 P00352 2/20 0.50
GRM5 P41594 1/20 0.50
TP53 P04637 1/20 0.50
PKM P14618 1/20 0.50
HPGD P15428 1/20 0.50
MAPK1 P28482 1/20 0.50
MAPT P10636 2/20 0.49
POLB P06746 1/20 0.49
GFER P55789 1/20 0.49
HTT P42858 1/20 0.49
KCNK3 O14649 1/20 0.48
KCNK9 Q9NPC2 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27811701 0.82 KMT2A (0.48) KMT2AMEN1RAB9ASMN1; SMN2NPC1
SCHEMBL559181 0.79 MAPT (0.47) KMT2AMEN1RAB9ANPC1HPGD
SCHEMBL559668 0.79 MAPT (0.52) KMT2AMEN1RAB9ANPC1ALDH1A1
SCHEMBL27790376 0.79 RAB9A (0.48) KMT2AMEN1RAB9ASMN1; SMN2NPC1
SCHEMBL2884626 0.78 SERPINE1 (0.69) KMT2AMEN1MAPTGFERHTT
SCHEMBL20522767 0.76 RAB9A (0.66) KMT2AMEN1RAB9ASMN1; SMN2NPC1
SCHEMBL20522702 0.76 KCNQ3 (0.56) KMT2AMEN1RAB9ASMN1; SMN2NPC1
SCHEMBL1814183 0.75 RAB9A (0.73) KMT2AMEN1RAB9ASMN1; SMN2NPC1
SCHEMBL3674558 0.74 KCNK3 (0.71) KMT2AMEN1RAB9ASMN1; SMN2NPC1
SCHEMBL2884838 0.73 ALDH1A1 (0.47) KMT2AMEN1RAB9ANPC1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100286215-A1 BIS-AROMATIC COMPOUNDS USEFUL IN THE TREATMENT OF INFLAMMATION BIS-AROMATIC COMPOUNDS USEFUL IN THE TREATMENT OF INFLAMMATION 2010-11-11 US disclosed
EP-2185504-A2 BIS-AROMATIC COMPOUNDS USEFUL IN THE TREATMENT OF INFLAMMATION Biolipox AB (SE) 2010-05-19 EP disclosed
WO-2009030887-A2 BIS-AROMATIC COMPOUNDS USEFUL IN THE TREATMENT OF INFLAMMATION BIOLIPOX AB (SE) 2009-03-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100286215-A1 BIS-AROMATIC COMPOUNDS USEFUL IN THE TREATMENT OF INFLAMMATION LTC4S, LTB4R2, LTB4R KMT2A 4223/4885MEN1 4015/4885RAB9A 3421/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.